Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01554488 · ClinicalTrials.gov registry record · Phase 4
Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease
A Phase 4 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT01554488: Clinical Trial Phase 4 study, sponsored by VA Office of Research and Development.
NCT01554488 is a Phase 4 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01554488, a Phase 4 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
The Chairman of the Veterans' Disability Benefits Commission reported at a recent US Senate hearing that asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are among the top 13 most frequent diagnoses leading to disability under the Department of Defense and the VA system statutes. Recent research finds that sleep apnea is more common among asthma and COPD individuals, and this may be caused by inhaled corticosteroid use. Many Veterans are currently using inhaled corticosteroids, and many more will be prescribed such medications, given their recent inclusion in international treatment guidelines. As such, this study addresses a critical need by researching the role of a potent inhaled corticosteroid in promoting sleep apnea, the determinants of this response, and the ways through which it occurs. Results from this study will form the foundation for future research aimed at expanding understanding of the effects of inhaled corticosteroids on the upper airway, as well as developing means to prevent or counteract them.
Interventions
- DRUG Inhaled Fluticasone Propionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-03-12 |
| Est. Completion | 2016-04-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01554488
The ClinicalTrials.gov registry entry for NCT01554488 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inhaled Fluticasone Propionate is the first listed.
NCT01554488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01554488 about?
NCT01554488 is a clinical study titled "Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease". The Chairman of the Veterans' Disability Benefits Commission reported at a recent US Senate hearing that asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea are among the top 13 most frequent diagnoses leading to disability under the Department of Defense and the VA system statutes...
What is the current status of trial NCT01554488?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2013-03-12. Estimated completion is 2016-04-07.
What interventions are being tested in trial NCT01554488?
The interventions under investigation include: Inhaled Fluticasone Propionate (DRUG).
Who is sponsoring clinical trial NCT01554488?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.